CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,023 enrolled
Drug / intervention
Counseling session +3 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01399359
NCT01399359N/ACompleted

A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer

NSABP Foundation Inc·observational·Posted Jul 21, 2011·Updated Oct 5, 2021

In Brief

An observational study evaluating Counseling session, Questionnaire 1, and 2 other interventions for Breast Cancer. Completed, enrolled 1,023 participants across 1 site.

Detailed Summary

RATIONALE: Learning about how patients make decisions about using chemoprevention may help doctors plan treatment in which more patients are willing to choose chemoprevention to reduce their breast cancer risk. PURPOSE: This clinical trial studies factors influencing decision-making about the use of chemoprevention in women at increased risk for breast cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 21, 2011
Enrollment StartAug 1, 2011
Primary CompletionOct 1, 2014
TodayJul 1, 2026
Enrollment to primary: 3.2 yearsPosted 14.9 years ago

Interventions

Counseling sessionbehavioral

Questionnaire 1other

Questionnaire 1 assesses the recall and understanding of risk information given during the counseling session.

Questionnaire 2other

Questionnaire 2 focuses on what factors, other thana the numerical risk-benefit analysis of SERM intake, are important in the decision-making process of women at increased risk for breast cancer.

online questionnaireother